Ákos Tamás Nagy

Mr. Ákos Tamás Nagy

Semmelweis University, Budapest, Hungary
orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2026 in Gels
Verified
Journal Article
Open access
PDF file
GSGyörgy Szmirnov
György Szmirnov
ISIlona Szmirnova
Ilona Szmirnova
ÁNÁkos Tamás Nagy
Ákos Tamás Nagy
KGKammerhofer Gábor
Kammerhofer Gábor
ZNZsolt Nemeth
Zsolt Nemeth
GSGyörgy Szabó
György Szabó
A propolis-based nano-formulated bioadhesive oral gel (NBF gel) containing vitamins C and E has been proposed as a supportive topical therapy for oral mucosal lesions. The aim of this study was to evaluate clinical outcomes associated with the use of the gel during a 15-year institutional clinical experience and to assess its adjunctive effect on periodontal status in patients with intellectual disabilities. The study consisted of two components: a retrospective observational case series and a non-randomized controlled clinical study. In the retrospective component, 295 patients (219 females and 76 males) received topical NBF gel treatment for various oral mucosal conditions, including xerostomia-associated mucositis, inflammatory lesions, aphthous ulcers, herpes infections, glossodynia, leukoplakia, erythroplakia, and post-surgical conditions. Treatment response was assessed descriptively using patient-reported symptom improvement combined with clinical evaluation. Overall, treatment was considered successful in 265/295 patients (89.8%), while 14/295 patients (4.7%) were classified as ineffective and 16/295 patients (5.4%) as inconclusive. More favorable responses were observed in inflammatory and post-treatment lesions than in potentially premalignant or neuropathic conditions. In the controlled periodontal component, 40 patients with mild to moderate intellectual disabilities were allocated into a control group performing toothbrushing alone and a test group additionally receiving topical NBF gel application. Periodontal status was assessed using the Basic Periodontal Examination (BPE) index at baseline and after 1 and 2 weeks. Adjunctive gel application was associated with greater improvement in periodontal status compared with toothbrushing alone. No clinically relevant adverse effects were documented during the observation period; however, because adverse events were not assessed using a predefined safety-monitoring protocol, these findings should be interpreted cautiously. The present findings suggest that the investigated nano-formulated bioadhesive oral gel may represent a potentially useful adjunctive topical therapy in selected oral mucosal and periodontal conditions. Further randomized controlled studies with standardized objective outcome measures are required to confirm these preliminary findings.

23 October 2026 in Gels
Verified
Journal Article
Open access
PDF file
ÁNÁkos Tamás Nagy
Ákos Tamás Nagy
SBSandor Bogdan
Sandor Bogdan
ÁJÁrpád Joób-Fancsaly
Árpád Joób-Fancsaly
GSGyörgy Szabó
György Szabó
Daniel VeghDaniel Vegh
Daniel Vegh
KGKammerhofer Gábor
Kammerhofer Gábor
Blue®M is an oral biomaterial product line based on active oxygen-generating formulations containing sodium perborate, honey-derived glucose oxidase, and lactoferrin, available as an oral gel, mouthwash, and toothpaste. This narrative review summarizes the human clinical evidence by product type and clinical indication, with a study-level risk of bias assessment. A structured search of PubMed/MEDLINE, Embase, CENTRAL, and Google Scholar, completed on 27 September 2026, identified 35 eligible human clinical studies. Risk of bias was formally assessed with the revised Cochrane risk of bias tool for 32 randomized trials, including split-mouth designs, and with ROBINS-I for three non-randomized comparative studies. The oral gel was mainly investigated as an adjunct to scaling and root planing and as a topical treatment for postoperative wounds. Periodontal findings were heterogeneous: probing pocket depth and attachment-level gains were reported in several small split-mouth trials with some concerns or serious risk, whereas no statistically significant between-group benefit was detected in the only trial that was at low risk of bias. Several small studies reported more favorable short-term pain and re-epithelialization outcomes than a conventional periodontal dressing, predominantly at high risk of bias. Mouthwash studies showed no statistically significant between-group differences compared with chlorhexidine, while toothpaste studies showed no consistent superiority over reference products. Overall, the available evidence, weighted by risk of bias, does not demonstrate superiority of Blue®M over established treatments; it may be regarded as a potentially useful adjunct whose comparative clinical value remains uncertain. Adequately powered randomized trials with a blinded outcome assessment, registered protocols, and active comparators are needed.

14 May 2026 in Gels
Verified
Journal Article
Open access
PDF file
KGKammerhofer Gábor
Kammerhofer Gábor
ÁNÁkos Tamás Nagy
Ákos Tamás Nagy
ÁJÁrpád Joób-Fancsaly
Árpád Joób-Fancsaly
GSGyörgy Szmirnov
György Szmirnov
ISIlona Szmirnova
Ilona Szmirnova
ZNZsolt Nemeth
Zsolt Nemeth
Oral mucosal and periodontal diseases are commonly associated with persistent inflammation, oxidative stress, impaired wound healing, and reduced oral health-related quality of life. Nano-Bio Fusion (NBF) gingival gel is a bioadhesive nano-formulated oral gel containing propolis, vitamin C, and vitamin E, developed for local application under oral soft tissue conditions. This critical narrative review aimed to evaluate the currently available evidence regarding the clinical applications, safety profile, and therapeutic potential of NBF gel in oral soft tissue therapy. A structured non-systematic literature search was performed using PubMed, Embase, Cochrane Library, and Google Scholar, and 16 relevant studies were included. The available evidence suggests that NBF gel may provide clinical benefits as an adjunct to non-surgical periodontal therapy, with reported improvements in plaque and gingival indices, periodontal probing depth, clinical attachment level, wound healing, and pain-related outcomes. In addition, potential beneficial effects have been reported in oral surgery-related wound healing, alveolar osteitis, desquamative gingivitis, erosive lichen planus, and xerostomia-associated mucositis. Several studies reported outcomes comparable to conventional therapies, including chlorhexidine-based regimens and locally delivered antimicrobials; however, the evidence remains heterogeneous and limited. Furthermore, the proposed biological mechanisms, including antioxidant, antimicrobial, and tissue-modulating effects, are not yet fully supported by mechanistic or pharmacokinetic evidence. The currently available literature is limited by heterogeneity in study design, small sample sizes, short follow-up periods, and limited independent validation. Therefore, further well-designed, adequately powered randomized controlled trials with standardized methodologies are required to better define the clinical role of NBF gel in evidence-based oral soft tissue therapy.